Diabetes Diagnostics Market, By Product Type (Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Systems, Testing Strips, Lancets and Lancing Devices, HbA1c Testing Kits, Ketone Testing Kits, Insulin Dose Calculators/Insulin Delivery Devices, and Others (e.g., smart wearables, emerging digital diagnostic tools)), By Testing Type (Self-Monitoring Blood Glucose (SMBG) Tests, Laboratory-Based Tests, and Point-of-Care (POC) Tests), By Diagnostic Technology (Electrochemical Biosensors, Optical Sensors, Enzymatic Assays, Immunoassays, Microfluidic Technology, and Others (e.g., next-gen nanotechnology-based diagnostics)), By Diabetes Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, and Prediabetes/Screening), By End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Ambulator, By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)